Search
Search Results
-
The role of thiol-disulfide homeostasis and ischemia-modified albumin in osteosarcopenia
BackgroundOxidative stress results from an imbalance between the induction of reactive oxygen species and the ability of cells to metabolize them....
-
Evaluation of calprotectin and ischemia-modified albumin serum levels as biomarkers to measure disease activity in Behçet’s disease
BackgroundAlthough several cytokines and markers have been recognized to assess disease activity in Behçet’s disease (BD), they are not routinely...
-
Diagnostic values of ischemia modified albumin in diabetes-related complications: a narrative review
PurposeOxidative stress (OS) plays a critical role in the onset and progression of macro and microvascular complications of diabetes mellitus (DM)....
-
Evaluation of the ischemia modified albumin levels in familial Mediterranean fever patients
BackgroundFamilial Mediterranean fever (FMF) is an autoimmune disease with periodic fever attacks recurring with mutations in the MEFV gene and...
-
Association of Maternal Serum Ischemia Modified Albumin (IMA) with Placental Histopathological Changes and Fetomaternal Outcome: A Prospective Case Control Study in Normotensive and Pre-eclamptic Women
IntroductionIschemia and oxidative stress leads to generation of hydroxyl free radicals and modification of ‘ N -terminus’ of human serum albumin....
-
Effect of an Albumin Infusion Treatment Protocol on Delayed Cerebral Ischemia and Relevant Outcomes in Patients with Subarachnoid Hemorrhage
BackgroundAn institutional management protocol for patients with subarachnoid hemorrhage (SAH) based on initial cardiac assessment, permissiveness of...
-
The effects of the renin–angiotensin–aldosterone system blockers on serum ischemia-modified albumin levels in autosomal dominant polycystic kidney disease
BackgroundAmong one of the common hereditary causes of chronic kidney disease is autosomal-dominant polycystic kidney disease (ADPKD), and its...
-
Ischemia-modified albumin and fibulin-5 as diagnostic and prognostic markers for acute cerebrovascular disease
BackgroundFibulin-5 and ischemia-modified albumin (IMA) levels increase in acute phase of cerebrovascular diseases, yet data regarding their levels...
-
Investigation of serum ischemia-modified albumin levels in coronary artery disease patients
ObjectiveIschemia-modified albumin (IMA) is a novel marker for the detection of ischemia. The value of this biomarker has been studied in patients...
-
Correlation between ischemia-modified albumin level and coronary collateral circulation
ObjectiveTo investigate the correlation between ischemia-modified albumin (IMA) levels and coronary collateral circulation (CCC) in patients with...
-
Impact of human serum albumin level on symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage
ObjectiveTo investigate the impact of human serum albumin (HSA) levels on symptomatic cerebral vasospasm (SCVS) in patients with aneurysmal...
-
Does ischemia-modified albumin level predict severity of obstructive sleep apnea?
Objective and aimIschemia-modified albumin (IMA) is a newly recognized marker of chronic inflammation used to evaluate oxidative stress status in...
-
Modification of ALPPS to avoid ischemia and congestion after stage 1: a case report
BackgroundAssociating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has been advocated for treating advanced liver tumors,...
-
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Ischemia-reperfusion (I/R) injury paradoxically occurs during reperfusion following ischemia, exacerbating the initial tissue damage. The limited...
-
Regular transient limb ischemia improves endothelial function and inhibits endothelial cell apoptosis to prevent atherosclerosis in rabbit
AimsRegular transient limb ischemia (RTLI) can prevent atherosclerosis (AS) progression in hypercholesterolemic rabbits. This study aimed to...
-
Identification of a mechanism promoting mitochondrial sterol accumulation during myocardial ischemia–reperfusion: role of TSPO and STAR
Hypercholesterolemia is a major risk factor for coronary artery diseases and cardiac ischemic events. Cholesterol per se could also have negative...
-
[D-Ala2, D-Leu5]-enkephalin (DADLE) provides protection against myocardial ischemia reperfusion injury by inhibiting Wnt/β-Catenin pathway
BackgroundAcute myocardial infarction is one of the leading causes of death worldwide. Myocardial ischemia reperfusion (MI/R) injury occurs...
-
Evaluation of the effects of empagliflozin on acute lung injury in rat intestinal ischemia–reperfusion model
BackgroundEmpagliflozin is a selective sodium–glucose co-transporter (SGLT2) inhibitor that is approved for the treatment of type 2 diabetes. The...
-
Hemodynamic Management in the Prevention and Treatment of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
One of the most serious complications after subarachnoid hemorrhage (SAH) is delayed cerebral ischemia, the cause of which is multifactorial. Delayed...
-
C-reactive Protein/Albumin Ratio as a Prognostic Indicator in Posttraumatic Shock and Outcome of Multiple Trauma Patients
ObjectiveC-reactive protein (CRP)/albumin ratio (CAR) is a new inflammation-based index for predicting the prognosis of various diseases. The CAR...
